| Literature DB >> 28639944 |
Sanliay Şahin1, Mutlu Uysal Yazıcı, Ganime Ayar, Tülin Köksal, İbrahim İlker Çetin, Filiz Ekici, Abdullah Kocabaş.
Abstract
OBJECTIVE: To determine the indication and necessity of echocardiographic assessment and therapeutic interventions in critically ill children.Entities:
Mesh:
Year: 2017 PMID: 28639944 PMCID: PMC5731263 DOI: 10.14744/AnatolJCardiol.2017.7659
Source DB: PubMed Journal: Anatol J Cardiol ISSN: 2149-2263 Impact factor: 1.596
Demographic characteristics of the patients
| Variables | MV (n=75) | SB (n=65) | |
|---|---|---|---|
| 4±5.1 (1.9) | 8.1±6.3 (6) | p<0.001 | |
| 0–1 | 31 (41.3) | 10 (15.4) | |
| 1–5 | 26 (34.7) | 17 (26.2) | |
| 5–10 | 4 (5.3) | 15 (23.1) | |
| 10–15 | 9 (12) | 6 (9.2) | |
| >15 | 5 (6.7) | 17 (26.2) | |
| Male, n (%) | 42 (56) | 38 (58.5) | p>0.05 |
| Female, n (%) | 33 (44) | 27 (41.5) | |
| 15.8±17.7 (9.2) | 30.7±23.3 (22) | p<0.001 | |
| 17.1±9.3 (14) | 7.2±8.4 (5) | p<0.001 | |
| p<0.05 | |||
| Infectious diseases | 18 (24) | 17 (26.2) | |
| Cardiogenic | 7 (9.3) | 2 (3.1) | |
| Pulmonary | 6 (8) | 1 (1.5) | |
| Neurological | 16 (21.3) | 8 (12.3) | |
| Hematological–oncological | 9 (12) | 6 (9.2) | |
| Metabolic | 6 (8) | 2 (3.1) | |
| Nephrological | – | 1 (1.5) | |
| Endocrinological | 1 (1.3) | 1 (1.5) | |
| Gastroenterological | 2 (2.7) | – | |
| Trauma/postoperative care | 9 (12) | 1 (1.5) | |
| Poisoning | 1 (1.3) | 26 (40) | |
| p<0.001 | |||
| Cardiovascular | 32 (42.7) | 8 (12.3) | |
| Respiratory | 75 (100) | 9 (13.8) | |
| Neurological | 67 (89.3) | 28 (43.1) | |
| Hematological | 19 (25.3) | 10 (15.4) | |
| Renal | 11 (14.7) | 1 (1.5) | |
| Hepatic | 22 (29.3) | 8 (12.3) | |
| p<0.001 | |||
| Noninvasive | 22 (29.3) | – | |
| Invasive | 72 (96) | – | |
| HFOV | 1 (1.3) | – | |
| Noninvasive | 3.7±2.2 (3) | – | |
| Invasive | 16.3±17.9 (9) | – | |
| HFOV | 2 days | – | |
| 20.6±20.7 (13) | 3.3±3.0 (2) | p<0.001 | |
Indications of echocardiography
| Indication | MV (n=66) | SB (n=30) | |
|---|---|---|---|
| Cardiac murmur/Suspected cardiac disease, n (%) | 3 (4.5) | 4 (13.2) | p<0.05 |
| Hypotension/Shock, n (%) | 24 (36.2) | 4 (13.2) | p<0.001 |
| Hypertension, n (%) | 6 ( | 3 ( | p<0.05 |
| Arrhythmia, n (%) | 9 (13.6) | 7 (23.1) | p<0.05 |
| Congestive heart failure symptom, n (%) | 2 ( | 1 (3.3) | p<0.05 |
| Pulmonary hypertension | 5 (6.7) | 2 (3.1) | p>0.05 |
| Others, n (%) | 22 (33.2) | 11 (33.3) | p<0.05 |
| Postcardiac arrest | 3 (4.5) | Ø | |
| Refractory hypoxia | 3 (4.5) | 1 (3.3) | |
| Organ donation | 1 (1.5) | Ø | |
| Initiation of renal replacement therapy/Chemotherapy | 5 (7.6) | 6 (19.8) | |
| Trauma/Postsurgery hemodynamic problems | 6 ( | 1 (3.3) | |
| Severe acidosis (Metabolic disease) | 1 (1.5) | 2 (6.7) | |
| Preoperative evaluation/before invasive procedures | 3 (4.5) | 1 (3.3) |
Therapeutic interventions performed after echocardiography
| Intervention | MV n (%) | SB n (%) |
|---|---|---|
| Insignificant cardiac problem —Follow-up recommended | 12 (18.1) | 12 (40) |
| Fluid replacement and regulation of vasopressor therapy | 44 (58.7) | 3 (10) |
| Regulation of antihypertensive therapy | 12 (16) | 2 (6.7) |
| Recommendation/regulation of antiarrhythmic therapy | 16 (21.3) | 7 (23.1) |
| Cardiac surgery | 3 (4.5) | Ø |
| Congestive heart failure treatment | 8 (10.7) | 1 (3.3) |
| Others | 13 (19.7) | 2 (6.7) |
| Pulmonary Hypertension therapy | 5 (7.6) | 1 (3.3) |
| Initiation/discontinuation/ alteration of other drugs | 8 (12.1) | 1 (3.3) |
| Additional investigations/ consultations recommended | 12 (18.1) | 3 (10) |
*Some patients had more than one cardiac problem and underwent more than one assessment